Dr. Utibe Essien: Who Gets Access to Innovative Treatments? (Health & Veritas Ep. 52)
On the Health & Veritas podcast, Yale physician-professors Howard Forman and Harlan Krumholz talk about the latest news and ideas in healthcare and seek out the truth amid the noise. In this episode, Harlan reports on a new study testing the effectiveness of the OCD drug fluvoxamine in treating COVID; Howie reflects on the potential of continuous glucose monitoring for people with diabetes. And they’re joined by Dr. Utibe Essien of the University of Pittsburgh to discuss the barriers preventing people of color from getting innovative new treatments and medications.

Utibe Essien
Listen now:
Links
“Prevalence and Correlates of Patient Rationing of Insulin in the United States: A National Survey”
Harlan Krumholz: “Life Expectancy after Myocardial Infarction by Hospital Performance”
Antiracism in Medicine podcast
“Intermittently Scanned Continuous Glucose Monitoring for Type 1 Diabetes”
Learn more about the MBA for Executives program at Yale SOM.
Email Howie and Harlan comments or questions.
Subscribe to Health & Veritas in Apple Podcasts, Spotify, Google Podcasts, or your favorite podcast player.
